How to Choose a Fertility Clinic After 35: Questions That Matter

Choosing a fertility clinic is one of the more consequential decisions in the fertility treatment process — and for women over 35, the choice often carries additional weight given the role that timing and protocol optimization can play in outcomes. Clinics vary considerably in their experience with older patients, their success rate reporting methods, their protocols, and their communication styles. Knowing which factors to evaluate can help narrow the options more systematically.

Ads

This guide outlines the categories of information most relevant to evaluating a fertility clinic after 35, along with specific questions that may be useful in consultations.

What Research Shows About Clinic Quality Variation

According to the CDC’s Assisted Reproductive Technology (ART) National Summary Report, success rates across IVF clinics in the United States vary significantly — even when controlling for patient age and diagnosis. The report collects data from clinics that perform ART procedures and is published annually. While it provides a useful starting point for comparisons, interpreting the numbers requires some care: clinics that work with higher proportions of complex cases, older patients, or patients who have failed at other clinics may show lower aggregate success rates while still offering excellent care for those specific populations.

The Society for Assisted Reproductive Technology (SART) maintains a clinic locator and publishes success rate data in a format designed to allow for some patient characteristic adjustments. Reviewing both CDC and SART data for clinics you’re considering can provide a more complete picture than either source alone.

How to Evaluate Success Rate Data

Ads

Success rates are among the most cited — and most misinterpreted — metrics in fertility clinic evaluation. A few considerations help contextualize what the numbers do and don’t tell you:

Look at Age-Specific Rates

Aggregate success rates for a clinic include all age groups. For women over 35, the relevant data is typically broken out into age brackets: 35–37, 38–40, and 41–42+. Rates in your specific age bracket may differ substantially from the clinic’s overall headline figure. CDC and SART data both report outcomes by patient age and egg type (own eggs vs. donor eggs).

Understand Which Outcome Is Being Reported

Different clinics may emphasize different outcome measures: positive pregnancy test, clinical pregnancy (heartbeat detected), or live birth rate. Live birth rate is generally considered the most meaningful endpoint for patients, as it reflects the full chain of outcomes rather than an intermediate measure. Confirming which metric a clinic is referencing when they cite a success rate is worth doing directly.

Ask About Patient Selection Practices

Some clinics decline to treat patients with particularly low prognosis, which can inflate published success rates. Others accept all patients and may show lower average rates as a result. Neither approach is inherently better — but understanding a clinic’s patient selection approach helps interpret their numbers more accurately.

Protocol and Personalization Questions

For women over 35, protocol choices — particularly stimulation approach, trigger timing, and embryo transfer decisions — can be clinically meaningful. A clinic’s willingness to discuss and individualize its approach is often a useful signal.

Stimulation Protocols

Different stimulation protocols (long lupron, antagonist, mini-IVF, and others) may be more or less appropriate depending on ovarian reserve, prior response, and clinical factors. Asking whether the clinic uses a standardized protocol for all patients or tailors it to individual test results and history can reveal how personalized the approach is likely to be.

Preimplantation Genetic Testing (PGT-A)

Whether and when to recommend PGT-A (chromosomal screening of embryos) is a topic on which clinics vary in their approach. For patients over 35, where chromosomal aneuploidy rates in embryos are higher, some clinics recommend PGT-A routinely while others take a more selective approach. Understanding a clinic’s philosophy — and the evidence behind it — is a reasonable question for a consultation. For context on what IVF itself involves financially, the costs of IVF after 35 are worth reviewing alongside any protocol discussion.

Fresh vs. Frozen Embryo Transfer

Most clinics now default to frozen embryo transfer (FET) for most patients, citing evidence of comparable or improved outcomes compared to fresh transfer in many scenarios. Some situations may favor one approach over the other. Asking about a clinic’s default approach and the reasoning behind it can help set expectations.

Cost Transparency and Financial Planning

Fertility treatment costs after 35 can be substantial, and how a clinic presents and structures its pricing matters for planning purposes. Understanding what insurance covers for fertility treatments before your first consultation can make the financial conversation more productive.

Itemized Cost Estimates

Request an itemized estimate that separates base procedure costs from separately billed components: monitoring appointments, anesthesia, laboratory fees, genetic testing, medications, and cryopreservation/storage. This allows for meaningful comparison across clinics and helps avoid surprises.

Multi-Cycle Programs and Refund Options

Some clinics offer multi-cycle “package” programs or refund programs for patients who don’t achieve a live birth after a specified number of cycles. These programs vary considerably in their terms, exclusion criteria, and actual value depending on a patient’s individual prognosis. Evaluating whether a program’s eligibility criteria apply to your situation and what the full terms are is worth doing carefully rather than taking headline marketing language at face value.

Practical Steps When Narrowing Your List

Beyond data and protocol questions, several practical factors tend to matter for the day-to-day experience of fertility treatment:

Location and monitoring logistics — IVF requires frequent early-morning monitoring appointments during a stimulation cycle. A clinic that’s geographically accessible or offers satellite monitoring partnerships can meaningfully affect the practical burden of a cycle.
Communication style and responsiveness — How quickly does the clinic respond to questions? Is there a patient portal? Do you have consistent contact with one physician or a rotating team? These factors affect the experience significantly.
Laboratory quality — The embryology laboratory is central to IVF outcomes. Asking about lab accreditation, fertilization rates, and blastocyst development rates (the percentage of fertilized eggs that reach the blastocyst stage) can provide some insight into lab quality, though these metrics also depend on patient population.
Second opinion availability — Seeking a second opinion before committing to a treatment plan or after an unsuccessful cycle is entirely reasonable and ethically appropriate. A clinic’s openness to this reflects on its culture.

Frequently Asked Questions

How do I find clinic success rate data?

The CDC publishes annual ART data at cdc.gov/art, and SART (sart.org) maintains a clinic search tool with outcome data reported by member clinics. Both sources allow filtering by clinic and patient age group. The data is typically published with a one-to-two-year lag, so recent changes to a clinic’s staff or laboratory may not be reflected in published figures. Using both sources together, and asking the clinic directly for their most current internal data, provides the most complete picture.

Is a higher success rate always better?

Not necessarily. Success rates reflect both clinical quality and patient selection practices. A clinic that accepts only patients with the most favorable prognosis will generally show higher rates than one that treats a broader population. For patients with complex histories or lower ovarian reserve, a clinic that specializes in difficult cases and is transparent about prognosis may be more appropriate than one with a high headline rate but limited experience with their specific situation.

Should I see a reproductive endocrinologist or a general OB/GYN for fertility treatment?

For women over 35 who have been trying to conceive for six months or more without success — or for those with known fertility-related conditions — seeing a reproductive endocrinologist (RE) is generally the appropriate next step. REs specialize in fertility evaluation and treatment and have training specific to IVF, ovarian stimulation, and the management of fertility challenges. Many OB/GYNs will refer directly to an RE for these cases.

What questions should I ask during a first consultation?

Useful questions for a first fertility clinic consultation include: What diagnostic tests would you recommend before proposing a treatment plan? Based on my age and any preliminary information, what treatment approach would you likely recommend? What success rates do you see for patients in my age group with a similar profile? What does a complete cost estimate look like for the recommended treatment? How do you communicate with patients during a cycle? These questions help set realistic expectations and allow you to compare responses across clinics.

Key Takeaways

CDC and SART both publish clinic success rate data; reviewing age-specific live birth rates rather than aggregate figures is more relevant for women over 35.
Success rates reflect both clinical quality and patient selection practices — context matters when comparing clinics.
Protocol individualization, lab quality, and cost transparency are clinically and practically meaningful factors beyond headline success rates.
Location, communication style, and monitoring logistics affect the day-to-day experience of treatment and are worth weighing alongside clinical factors.
Seeking a second opinion is reasonable at any point in the process and is generally well-supported within the reproductive medicine field.